Alistrol
Alistrol, licence 80047013: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- BeGood Supplements Heart Health Support, Planet Earth Supplements Heart Health Support
- Licence holder
- Commodity-Link.com Enterprises Ltd.
- NPN or DIN-HM
- 80047013
- Status
- Active licence
- Licence date
- 10 December 2013
- Revision date
- 25 March 2019
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ilex cornuta Source : Feuille Extraction ratio : 15:1 Dry plant equivalent : 1890 mg | 126.0 mg | Not calculated |
| Allium sativum Source : Bulbe Extraction ratio : 15:1 Dry plant equivalent : 450 mg | 30.0 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Fruit de l'aubépine chinoise, Stéarate de magnésium, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3.0 Capsule | 2.0 Jour(s) |
Uses authorised in Canada
Used in Herbal Medicine to help maintain cardiovascular health in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case discontinue use.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner before using this product if you have a medical condition or are taking prescription medications. Consult a health care practitioner if symptoms persist or worsen.
Source
Official Health Canada record, licence 80047013
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.